Related Experiment Video
Updated: Jun 12, 2026
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate
Alexandre Dos Santos1, Magali Court, Valérie Thiers
1Unité 785, INSERM, Villejuif, France.
Abstract:
Obtaining accurate protein profiles from homogeneous cell populations in heterogeneous tissues can enhance the capability to discover protein biomarkers. In this context, methodologies to access specific cellular populations and analyze their proteome with exquisite sensitivity have to be selected. We report here the results of an investigation using a combination of laser microdissection and accurate mass and time tag proteomics. The study was aimed at the precise determination of proteome alterations in intrahepatic cholangiocarcinoma ICC, a markedly heterogeneous tumor. This cancer, which is difficult to diagnose and carries a very poor prognosis, has shown an unexplained increase in incidence over the last few years. Among a pool of 574 identified proteins, we were able to report on altered abundance patterns affecting 39 proteins conforming to a variety of potential tumorigenic pathways. The reliability of the proteomics results was confirmed by Western blot and immunohistochemistry on matched samples. Most of the proteins displaying perturbed abundances had not yet been described in the setting of ICC. These include proteins involved in cell mobility and actin cytoskeleton remodeling, which may participate in the epithelial to mesenchymal transition, a process invoked in migration and invasion of cancer cells. The biological relevance of these findings was explored using a tissue microarray. An increased abundance of vimentin was thus detected in 70% of ICC and none of the controls. These results suggest that vimentin could play a role in the aggressiveness of ICC and provide a basis for the serious outcome of this cancer.
Insights
This study identifies 39 altered proteins in intrahepatic cholangiocarcinoma (ICC) using laser microdissection and proteomics. Vimentin was significantly upregulated, suggesting its role in ICC aggressiveness and poor prognosis.
Area of Science:
- Proteomics
- Cancer Biology
- Biomarker Discovery
Background:
- Intrahepatic cholangiocarcinoma (ICC) is a heterogeneous tumor with poor prognosis and increasing incidence.
- Accurate protein profiling of specific cell populations is crucial for biomarker discovery.
- Current diagnostic and therapeutic strategies for ICC are limited.
Purpose of the Study:
- To precisely determine proteome alterations in intrahepatic cholangiocarcinoma (ICC).
- To identify potential protein biomarkers associated with ICC tumorigenesis and aggressiveness.
- To investigate the role of specific proteins in ICC progression.
Main Methods:
- Combination of laser microdissection and accurate mass and time tag (TMT) proteomics.
- Proteomic analysis of homogeneous cell populations isolated from heterogeneous ICC tumors.
- Validation of proteomic findings using Western blot and immunohistochemistry.
- Tissue microarray analysis to assess biological relevance of identified proteins.
Main Results:
- Identified 574 proteins, with 39 showing altered abundance patterns in ICC.
- Discovered novel proteins implicated in potential tumorigenic pathways, including cell mobility and actin cytoskeleton remodeling.
- Confirmed increased abundance of vimentin in 70% of ICC samples compared to controls.
- Western blot and immunohistochemistry validated the reliability of proteomic results.
Conclusions:
- The study identified novel protein alterations in ICC, offering insights into its pathogenesis.
- Upregulation of proteins involved in cell mobility, such as vimentin, suggests a role in ICC invasion and aggressiveness.
- Vimentin may serve as a potential biomarker for the poor prognosis associated with ICC.
